Hilltop Holdings Inc. Has $4.24 Million Position in Danaher Co. (NYSE:DHR)

Hilltop Holdings Inc. raised its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 56.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,239 shares of the conglomerate's stock after purchasing an additional 5,506 shares during the period. Hilltop Holdings Inc.'s holdings in Danaher were worth $4,237,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. FMR LLC boosted its holdings in Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares during the period. TD Asset Management Inc boosted its holdings in Danaher by 99.0% in the second quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate's stock worth $339,473,000 after purchasing an additional 675,952 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Danaher by 22.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock worth $761,475,000 after purchasing an additional 563,546 shares during the period. International Assets Investment Management LLC boosted its holdings in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock worth $119,539,000 after purchasing an additional 428,897 shares during the period. Finally, Montrusco Bolton Investments Inc. boosted its holdings in shares of Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock valued at $465,617,000 after acquiring an additional 397,671 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. KeyCorp boosted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a report on Wednesday, October 23rd. Raymond James reduced their price target on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Stifel Nicolaus boosted their price target on shares of Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a report on Wednesday, October 23rd. Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating on the stock in a research note on Wednesday, October 23rd. Finally, Evercore ISI lifted their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $287.16.

Danaher Trading Down 0.2 %

NYSE DHR traded down $0.42 on Tuesday, hitting $240.87. 3,035,246 shares of the company were exchanged, compared to its average volume of 2,756,642. The company's 50 day moving average price is $254.59 and its 200-day moving average price is $259.41. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market capitalization of $173.98 billion, a P/E ratio of 46.04, a price-to-earnings-growth ratio of 4.41 and a beta of 0.83. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. During the same quarter in the previous year, the business posted $2.02 EPS. The business's revenue for the quarter was up 3.1% on a year-over-year basis. Analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher's payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.